Expert Highlights Immunotherapy Use in Stage III NSCLC – OncLive
OncLive |
Expert Highlights Immunotherapy Use in Stage III NSCLC
OncLive OncLive: Can you highlight potential uses of immunotherapy for stage III locally advanced disease? Schwartz: Immunotherapy is a very exciting topic right now, and we've seen incredible promise with it. We're still trying to differentiate which agents … |
